The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 29, 2014

Filed:

May. 18, 2012
Applicants:

Daniel A. Gamache, Arlington, TX (US);

Laman Alani, Fort Worth, TX (US);

Malay Ghosh, Fort Worth, TX (US);

Francisco Javier Galán, Barcelona, ES;

Núria Carreras Perdiguer, Barcelona, ES;

Onkar N. Singh, Arlington, TX (US);

Inventors:

Daniel A. Gamache, Arlington, TX (US);

Laman Alani, Fort Worth, TX (US);

Malay Ghosh, Fort Worth, TX (US);

Francisco Javier Galán, Barcelona, ES;

Núria Carreras Perdiguer, Barcelona, ES;

Onkar N. Singh, Arlington, TX (US);

Assignee:

Alcon Research, Ltd., Fort Worth, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/335 (2006.01); A61K 47/48 (2006.01); C08B 37/16 (2006.01); C08L 5/16 (2006.01); A61K 9/08 (2006.01); A61K 9/00 (2006.01); A61K 47/32 (2006.01);
U.S. Cl.
CPC ...
A61K 31/335 (2013.01); A61K 47/48969 (2013.01); C08B 37/0015 (2013.01); C08L 5/16 (2013.01); A61K 47/32 (2013.01); A61K 9/08 (2013.01); A61K 9/0048 (2013.01);
Abstract

The present invention is an ophthalmic composition containing a relatively high concentration of olopatadine. The composition is typically an ophthalmic aqueous solution containing relatively high concentrations of olopatadine solubilized within the solution. The composition is preferably capable of providing enhanced relief from symptoms of ocular allergic conjunctivitis, particularly late phase symptoms of ocular allergic conjunctivitis.


Find Patent Forward Citations

Loading…